The impact of the COVID-19 pandemic on ADHD medicine consumption in 47 countries and regions

The objective of this study is to quantify the impact of the COVID-19 pandemic on attention deficit hyperactivity disorder (ADHD) medication consumption globally and nationally using pharmaceutical sales data from 2014 to 2021 across 47 countries and regions. A seasonal autoregressive integrated mov...

Descripción completa

Detalles Bibliográficos
Autores principales: Gimbach, Sophie, Vogel, Daniel, Fried, Roland, Faraone, Stephen V., Banaschewski, Tobias, Buitelaar, Jan, Döpfner, Manfred, Ammer, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106831/
https://www.ncbi.nlm.nih.gov/pubmed/37119560
http://dx.doi.org/10.1016/j.euroneuro.2023.04.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106831/
https://www.ncbi.nlm.nih.gov/pubmed/37119560
http://dx.doi.org/10.1016/j.euroneuro.2023.04.008

Ejemplares similares